[Clinical study on zhengan xifeng decoction in preventing and treating hypertensive nephropathy].
Seventeen cases of hypertensive nephropathy with azotemia (test group) treated with Zhengan Xifeng Decoction (ZGXFI) and routine regimen of Western Medicine were observed. The result was compared with that of 15 cases treated with routine regimen alone (control group). After 3 months of treatment, the blood pressure, sodium excretion, blood urea nitrogen and creatinine were all reduced, while creatinine clearance rate (CCr) and residual renal function index (RRFI) were improved significantly in both groups. Compared with control group, the treatment on test group showed a more prominent effect on lowering of diastolic blood pressure, elevating the hemoglobin, reducing the blood level of triglyceride and creatinine as well as improving on CCr and RRFI, suggesting the deterioration of residual renal function could be restrained by ZGXFD, through improve the disorder of lipid metabolism, osmolality gradient and creatinine kinetics.
Zhang
B K
BK
Xijing Hospital, 4th Military Medical University, Xi'an.
Zhao
Z H
ZH
D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009400:Nephrosclerosis / Q000097:blood / Q000188:drug therapy*; D014511:Uremia / Q000097:blood / Q000188:drug therapy*
D004365:Drugs, Chinese Herbal; D006454:Hemoglobins; D008055:Lipids